US Patent:
20230012687, Jan 19, 2023
Inventors:
- Cambridge MA, US
Christian Dombrowski - Auburndale MA, US
Seth C. Alexander - Medford MA, US
Assignee:
Intellia Therapeutics, Inc. - Cambridge MA
International Classification:
C12N 15/67
C12N 9/22
C12N 15/90
C12N 15/88
C12N 15/11
Abstract:
Compositions and methods for gene editing. In some embodiments, a polynucleotide encoding Cas9 is provided that can provide one or more of improved editing efficiency, reduced immunogenicity, or other benefits.